surpass-cvot tirzepatide trial: was non-inferior to dulaglutide and superior to putative placebo for reducing the composite of CV death/HF events in patients with T2D and ASCVD. #AHA25 View the slides here: https://t.co/6VQpBHFP2I Overview of the SURPASS clinical

Qu es Mounjaro y cmo funciona

Establishing a consistent eating schedule with regular meal times helps regulate appetite hormones disrupted by weight loss

3 Incidence of nausea, vomiting, and diarrhea over time

Similarly, tirzepatides phase 2 results in the SYNERGY-NASH trial have laid the groundwork for phase 3 development in metabolic steatohepatitis [44]

[Google Scholar] 26

Gender-Differentiated AE Signals The findings regarding gender-differentiated AE signals of tirzepatide provide critical insights into personalized pharmacovigilance, aligning with emerging evidence on sex-related disparities in the safety profiles of GLP-1 receptor agonists